Puquitinib mesylate, an inhibitor of phosphatidylinositol 3-kinase p110δ, for treating relapsed or refractory non-Hodgkin's lymphoma.

about

Puquitinib, a novel orally available PI3Kδ inhibitor, exhibits potent antitumor efficacy against acute myeloid leukemia Determination of Puquitinib in Human Plasma by HPLC-ESI MS/MS: Application to Pharmacokinetic Study.

P2860

Q33873323-DF965609-756E-4467-BCFB-60EC47D0035A Q52665380-205D6B98-FD62-418C-BFED-D776718703BF

P2860

Puquitinib mesylate, an inhibitor of phosphatidylinositol 3-kinase p110δ, for treating relapsed or refractory non-Hodgkin's lymphoma.

Item

http://www.wikidata.org/entity/Q36685569

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Puquitinib mesylate, an inhibi ...... actory non-Hodgkin's lymphoma.

@ast

Puquitinib mesylate, an inhibi ...... actory non-Hodgkin's lymphoma.

@en

type

Item

label

Puquitinib mesylate, an inhibi ...... actory non-Hodgkin's lymphoma.

@ast

Puquitinib mesylate, an inhibi ...... actory non-Hodgkin's lymphoma.

@en

prefLabel

Puquitinib mesylate, an inhibi ...... actory non-Hodgkin's lymphoma.

@ast

Puquitinib mesylate, an inhibi ...... actory non-Hodgkin's lymphoma.

@en

P1476

Puquitinib mesylate, an inhibi ...... actory non-Hodgkin's lymphoma.

@en

P2093

Ben-Yan Zou

http://www.w3.org/2001/XMLSchema#string

Hang Yang

http://www.w3.org/2001/XMLSchema#string

Jing Zhan

http://www.w3.org/2001/XMLSchema#string

Pan-Pan Liu

http://www.w3.org/2001/XMLSchema#string

Peng Sun

http://www.w3.org/2001/XMLSchema#string

Su Li

http://www.w3.org/2001/XMLSchema#string

Wen-Qi Jiang

http://www.w3.org/2001/XMLSchema#string

Xi-Wen Bi

http://www.w3.org/2001/XMLSchema#string

Yi Xia

http://www.w3.org/2001/XMLSchema#string

Yu Wang

http://www.w3.org/2001/XMLSchema#string

P2860

The PI3K pathway as drug target in human cancer

Management of metabolic effects associated with anticancer agents targeting the PI3K-Akt-mTOR pathway

First-in-human phase I study of pictilisib (GDC-0941), a potent pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor, in patients with advanced solid tumors.

The phosphoinositide 3-kinase pathway

Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice

Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation

The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

Targeting the phosphoinositide 3-kinase pathway in cancer

Targeting PI3K signalling in cancer: opportunities, challenges and limitations

Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer.

P304

44049-44056

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.5833

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283324863

http://www.w3.org/2001/XMLSchema#string

P698

26510909

http://www.w3.org/2001/XMLSchema#string

P932

4791286

http://www.w3.org/2001/XMLSchema#string

Puquitinib mesylate, an inhibitor of phosphatidylinositol 3-kinase p110δ, for treating relapsed or refractory non-Hodgkin's lymphoma.

about

P2860

P2860

Puquitinib mesylate, an inhibitor of phosphatidylinositol 3-kinase p110δ, for treating relapsed or refractory non-Hodgkin's lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932